Navigation Links
Kessler Foundation Identifies Six Participants to Test Ekso
Date:10/14/2011

WEST ORANGE, N.J., Oct. 14, 2011 /PRNewswire/ -- Kessler Foundation, in collaboration with Kessler Institute for Rehabilitation, announced that it has selected six participants for the Ekso exoskeleton investigational studies, which will commence October 17.  Made by Ekso Bionics, Ekso is a wearable, robotic, battery-powered exoskeleton that enables wheelchair users to stand and walk.

Ekso Bionics announced the rebranding of both its company name and product line on October 13, 2011. It was formerly known as Berkeley Bionics and the Ekso exoskeleton was formerly known as eLEGS.

Kessler is one of ten centers across the U.S. to partner with Ekso Bionics to develop protocols and examine how the overall health of individuals with spinal cord injury improves with Ekso. During the week of October 17th, representatives from Ekso Bionics will train staff and research participants at Kessler on using the exoskeleton. Gail Forrest, PhD, Interim Director of Human Performance and Movement Analysis Research at Kessler Foundation, and Steven Kirshblum, MD, Medical Director and Director of Spinal Cord Injury Rehabilitation at Kessler Institute for Rehabilitation, will lead a collaborative team for the investigational study. Kessler will acquire its own Ekso for research and clinical use in January 2012.

"This technology provides hope that individuals with paralysis and lower extremity weakness can walk," said Dr. Kirshblum. "Through our collaboration, we bring innovative technology directly to patient care when conducting clinical trials."

Kessler is also one of seven centers in the Christopher and Dana Reeve NeuroRecovery Network, a program designed to retrain the nervous system through intensive repetitive locomotor training—during which the individual is harnessed over a treadmill as therapists move the legs in a walking motion. Other avenues of exploration for Kessler include Hocoma's LokomatPro V6 and epidural stimulation. The Lokom
'/>"/>

SOURCE Kessler Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kessler is the First Rehabilitation Center in the Nation to Use New Robotic Gait Training System
2. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
3. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
6. CVS Caremark Partners With Hispanic Heritage Foundation to Identify and Inspire Future Latino Health Care Leaders
7. Amerigroup Foundation Presents Grant to Rx Partnership in Virginia
8. Solos Endoscopy to Support National Breast Cancer Foundation With Sales of Its MammoView® Breast Endoscopy Components to US Hospitals
9. Media Alert: Elekta to Present $50,000 to Miami-Based Sandy B. Muller Breast Cancer Foundation at ASTRO Annual Meeting
10. Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors
11. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... YORK , April 21, 2015 EpiCast ... Summary Sepsis is a life-threatening complication arising from ... the infection damages its own tissues and organs. Anyone ... among children <1 year of age, older ... 2014). Global estimates for the year 2013 showed that ...
(Date:4/21/2015)... -- Global cap & closure demand to ... and closures will exceed $55 billion in 2019. In unit ... Beverages will continue to account for well over half of ... smaller markets are expected to register faster growth. ... developed markets -- the US, Western Europe ...
(Date:4/21/2015)... 21, 2015 Gary A. Puckrein , ... Quality Forum (NMQF), today will present an award ... Pharmaceutical Research and Manufacturers of America (PhRMA), for ... On behalf of PhRMA, and in conjunction with NMQF, ... build awareness, start conversations, and increase diversity in clinical ...
Breaking Medicine Technology:EpiCast Report: Sepsis - Epidemiology Forecast to 2023 2EpiCast Report: Sepsis - Epidemiology Forecast to 2023 3World Caps & Closures Market 2World Caps & Closures Market 3National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Double-Blind Study Targets Biomarker-Defined Population, BERKELEY ... GNTA ) announced that the first ... Phase 3 trial of Genasense,(oblimersen sodium) Injection ... is a randomized, double-blind, placebo-controlled study in ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5
(Date:4/21/2015)... April 21, 2015 On April 2, ... Trying to Achieve Kylie Jenner Lips With ... have injured themselves while attempting an at-home lip ... Twitter is that creating an airlock around one’s mouth ... to plump and achieve Kylie Jenner’s now famous pout. ...
(Date:4/21/2015)... Texas (PRWEB) April 22, 2015 ... Review, H1 2015” provides comparative analysis on ... report strengthens R&D pipelines by identifying new ... best-in-class products. Complete report with TOC is ... The report also reviews key players involved ...
(Date:4/21/2015)... The California Healthcare Institute (CHI), ... sciences organizations, released the following statement by CHI ... Assembly Bill (AB) 463: , “As innovators in ... of treatments and cures for patients with serious ... AB 463, the so-called Pharmaceutical Cost Transparency Act ...
(Date:4/21/2015)... Vancouver, BC (PRWEB) April 21, 2015 ... offers complimentary pick-up and delivery for clients that avail ... South Surrey by Angelo’s is done with hi-tech equipments, ... inconvenience for customers. They use all natural, high pressure ... as well as hand washing for area rugs made ...
(Date:4/21/2015)... Danvers, MA (PRWEB) April 21, 2015 ... managed mobility services, has been recognized by the Boston ... Massachusetts. The ranking was announced at a recent ... Journal’s annual list of the fastest-growing private companies in ... held businesses in the state that recorded the fastest ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2
... 2 MedWaves, Inc. announces the receipt of ... is in addition to having already received U.S. ... Microwave Coagulation/Ablation System for surgical applications. The system ... interventional radiologists to treat soft tissue problems, such ...
... BEACH, Va., Feb. 2 AMERIGROUP Corporation (NYSE: ... plan in the State of Nevada began offering healthcare ... Children,s Health Insurance (SCHIP) programs beginning February 1, 2009. ... of Nevada," said James G. Carlson, AMERIGROUP Chairman and ...
... in customer and technical supportPORTLAND, Ore., Feb. 2 ... Vice President of Customer Support. With nearly 20 years ... managing customer inquiries, special service requests, and technical support ... leadership, she has also developed new programs to smooth ...
... Opportunity Partners, LLC ("Xmark"), the sole member of the investment ... Ltd., has, in the past, sent letters to the Board ... setting forth its dissatisfaction with the company,s corporate governance, management ... opportunity to respond to the Form 8-K filed by the ...
... Mich., Feb. 2 Dorothy Carpenter had stomach problems her ... or pasta could lead to terrible pain.Her illness went undiagnosed ... System physician recognized it as celiac disease. By then her ... forced doctors to remove part of her small intestine."I,ve been ...
... JOLLA, Calif., Feb. 2 Transdel Pharmaceuticals, ... ), a specialty pharmaceutical company focused on ... has retained FLP Pharma, a Georgia-based pharmaceutical ... especially the out-licensing of its lead product ...
Cached Medicine News:Health News:MedWaves, Inc. Announces Receipt of MDD CE Certification and Additional U.S. FDA 510(k) Clearance to Market Its Patented Microwave Coagulation/Ablation System and Devices 2Health News:AMERIGROUP Health Plan in Nevada Begins Serving Medicaid Enrollees 2Health News:GI Condition Once Thought Rare is Common in U.S. 2Health News:GI Condition Once Thought Rare is Common in U.S. 3Health News:Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities 2Health News:Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities 3
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Rapid immunochromatographic membrane test for RSV. Accepts nasopharyngeal washes, aspirates, and swabs....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: